Lidco experiences strong demand amid Covid-19 pandemic
24th Aug 2020 08:07
(Sharecast News) - Hemodynamic monitoring company Lidco said on Monday that it had witnessed exceptional demand for its services during the ongoing Covid-19 pandemic.
Read moreLiDCO notes increased sales demand in China amid virus outbreak
9th Mar 2020 09:27
(Sharecast News) - AIM-listed LiDCO, a supplier of hemodynamic equipment, said on Monday that its Chinese distribution partner has recently sold "a small number" of monitors in Wuhan, China, as a result of the Covid-19 outbreak.
Read moreLidco upbeat after 'excellent' second half performance
13th Feb 2020 16:00
(Sharecast News) - Haemodynamic monitoring company Lidco updated the market on its just-ended financial year on Thursday, reporting that it continued to make progress with developing a strong recurring revenue base through its software-as-a-service (SaaS) high usage programme (HUP) model, and had achieved an "excellent" second half performance.
Read moreLidco upbeat as it launches new monitor in China
5th Nov 2019 14:00
(Sharecast News) - Haemodynamic monitoring company Lidco announced on Tuesday that the 'LiDCOrapidv3' monitor - its latest cardiac output monitor with non-invasive technology - has been launched in China at the 27th Annual Meeting of the Chinese Society of Anesthesiology in Hangzhou.
Read moreLidco revenue slips as it focuses on its own products
15th Oct 2019 11:09
(Sharecast News) - Hemodynamic monitoring provider Lidco reported product revenues, excluding third-party products, of £3.3m in its first half on Tuesday, which was an improvement of 10% year-on-year.
Read moreLidco product revenues grow despite migration of customers to SaaS platform
20th Aug 2019 10:36
(Sharecast News) - Hemodynamic monitoring company Lidco saw product revenues grow in the first half of its trading year despite many of its biggest UK customers transitioning to the group's Software-as-a-Service High Usage Programme business model.
Read moreRevenues exceed expectations for LiDCO in first quarter
16th May 2019 09:57
(Sharecast News) - Hemodynamic monitoring company LiDCO said it had made a "good start" to the year on Thursday, with first quarter revenues said to be "well ahead" of the same time last year, and above the board's expectations.
Read moreLiDCO climbs after winning Latin American distribution deal
12th Mar 2019 10:32
(Sharecast News) - LiDCO's shares climbed on Tuesday after the company signed a master distribution agreement for LiDCO products with Brazil-based Elysian Fields Medical covering a number of territories across Latin America.
Read moreLidco's recurring revenues soar as HUP offering picks up steam
20th Feb 2019 08:11
(Sharecast News) - Hemodynamic monitoring outfit Lidco saw recurring revenues soar in its last trading year after the group made continued progress with its high usage programme (HUP) business model in the first 18 months since its launch.
Read moreLiDCO drops as lumpy US market keeps revenues flat
17th Dec 2018 09:14
(Sharecast News) - LiDCO shares dropped on Monday after reporting that annual revenues will be "similar to the last financial year" as the drug monitoring company has been affected by longer US sales cycles and a big tweak to its UK business model.
Read moreLidco's losses widen as UK revenue stumbles
9th Oct 2018 09:51
(Sharecast News) - Lidco reported that its first half losses deepened on Tuesday after revenues suffered from a longer than expected sales cycle.
Read moreLiDCO announces further US success as revenues decline
20th Aug 2018 14:21
(Sharecast News) - Hemodynamic monitoring company LiDCO updated the market on its trading on Monday, announcing that it had further success in the US, contracting three additional customers to its recently-launched differentiated 'high usage programme (HUP) business model.
Read moreLiDCO posts extensive trading update
14th Feb 2017 12:46
(ShareCast News) - Cardiovascular monitoring company LiDCO Group provided a trading update for the full year to 31 January on Tuesday, with product revenues in the period expected to be up 14% to £6.76m, with total revenues - including third party products - expected to be up by 8% to £8.21m. The AI
Read moreLiDCO appoints Shane Doorish as head of North America
10th Jan 2017 11:50
(ShareCast News) - Hemodynamic monitoring company LiDCO announced the appointment of Shane Doorish as head of North America on Tuesday, with immediate effect. The AIM-traded firm said Doorish was bringing with him 19 years of experience in the healthcare sector having originally trained as a critica
Read moreLiDCO narrows loss in first half
11th Oct 2016 11:37
(ShareCast News) - Hemodynamic monitoring company LiDCO announced its unaudited interim results for the six months to 31 July on Tuesday, with product revenues up 10% to £3.03m. The AIM-traded firm's total product revenues, including third party products, was up 5% to £3.77m, with US revenues up 37%
Read more